Viewing Study NCT00574093


Ignite Creation Date: 2025-12-25 @ 1:01 AM
Ignite Modification Date: 2026-02-26 @ 2:15 AM
Study NCT ID: NCT00574093
Status: COMPLETED
Last Update Posted: 2009-10-30
First Post: 2007-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD
Sponsor: Fondazione G.B. Bietti, IRCCS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Age Related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None combination therapy View
None Lucentis View
None Visudyne View